EP
BBNX icon

Essential Partners’s Beta Bionics BBNX Stock Holding History

Essential Partners’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.54K Sell
98
-2,291
-96% -$27.2K ﹤0.01% 2076
2026
Q1 		$23.9K Buy
2,389
+2,243
+1,536% +$33.2K 0.01% 857
2025
Q4 		$4.45K Hold
146
– – ﹤0.01% 1477
2025
Q3 		$2.9K Hold
146
– – ﹤0.01% 1650
2025
Q2 		$2.13K Buy
+146
New +$2.07K ﹤0.01% 1300

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Essential Partners's BBNX Position: Q2 2026 in Review

Essential Partners reduced its Beta Bionics (BBNX) stake by 96% in Q2 2026, selling an estimated $27.2K and leaving 98 shares worth $1.54K. The position accounts for ﹤0.01% of the portfolio, ranked #2076.

Essential Partners first reported a position in BBNX in Q2 2025 and has held it in 5 quarters since. The position peaked at $23.9K in Q1 2026. 133 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Essential Partners held 98 shares of Beta Bionics worth $1.54K as of Q2 2026.
  • Essential Partners sold 2,291 Beta Bionics shares in Q2 2026, an estimated $27.2K.
  • Beta Bionics made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #2076 holding.
  • Essential Partners first reported a position in Beta Bionics in Q2 2025 and has held it in 5 quarters since.
  • Essential Partners's Beta Bionics position peaked at $23.9K in Q1 2026.
  • 133 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.